Directory
>
Lorna Ewart
Lorna Ewart
Non Executive Director | Emulate, Inc.
United Kingdom
Lorna Ewart
Summary
Lorna Ewart is an accomplished Chief Scientific Officer at Emulate, Inc., where she leads innovative efforts in drug discovery through advanced in vitro biological models. With a PhD in Pharmacology and extensive experience in the pharmaceutical industry, including a significant tenure at AstraZeneca, she has a robust background in safety pharmacology and cell biology. Lorna's leadership extends to her role as a Non-Executive Director at Carcinotech, where she contributes to the development of groundbreaking medical technologies. Her work is characterized by a commitment to human-centric models that enhance drug efficacy and safety. Lorna is also a published author in prominent scientific journals, reflecting her dedication to advancing the field of translational science. She holds several prestigious awards, including Fellowships from the Royal Society of Biology and the British Pharmacological Society, showcasing her influence and recognition in the scientific community. Her career trajectory highlights a blend of strategic leadership and scientific innovation, positioning her as a key figure in the life sciences sector.
Lorna Ewart
Work Experience
Non Executive Director at
Carcinotech Ltd
January 2024 - Present
Chief Scientific Officer at
Emulate, Inc.
February 2022 - Present
Founder and Managing Director at
VEROLI CONSULTING LIMITED
August 2019 - Present
Executive Vice President at
Emulate, Inc.
December 2019 - February 2022
Head of Microphysiological Systems Centre of Excellence, Innovative Medicines at
AstraZeneca
November 2016 - August 2019
Chief of Staff; Head of Strategy and Enabling Services at
AstraZeneca
February 2015 - November 2016
Director Toxicology Projects (Respiratory, Inflammation and Autoimmune) at
AstraZeneca
October 2013 - February 2015
Global Strategy Lead at
AstraZeneca
January 2013 - December 2013
Principal Scientist at
AstraZeneca
November 1998 - December 2012
Lorna Ewart
Education
University of Aberdeen, 1st Class Bsc Honours
Frequently Asked Questions about Lorna Ewart
What is Lorna Ewart email address?
Lorna Ewart's primary email address is ***********@emulatebio.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Lorna Ewart work for?
Lorna Ewart is a Non Executive Director at Emulate, Inc., a company specializing in Commercial physical research.
Where Lorna Ewart graduated from?
Lorna Ewart holds a degree in Pharmacology from Queen Mary University of London.
How can I directly contact Lorna Ewart?
To contact Lorna Ewart directly, you can use the email address ***********@emulatebio.com. Complete contact information is available upon registration with Muraena.
Who is Lorna Ewart?
Lorna Ewart is an accomplished Chief Scientific Officer at Emulate, Inc., where she leads innovative efforts in drug discovery through advanced in vitro biological models. With a PhD in Pharmacology and extensive experience in the pharmaceutical industry, including a significant tenure at AstraZeneca, she has a robust background in safety pharmacology and cell biology. Lorna's leadership extends to her role as a Non-Executive Director at Carcinotech, where she contributes to the development of groundbreaking medical technologies. Her work is characterized by a commitment to human-centric models that enhance drug efficacy and safety. Lorna is also a published author in prominent scientific journals, reflecting her dedication to advancing the field of translational science. She holds several prestigious awards, including Fellowships from the Royal Society of Biology and the British Pharmacological Society, showcasing her influence and recognition in the scientific community. Her career trajectory highlights a blend of strategic leadership and scientific innovation, positioning her as a key figure in the life sciences sector.
Lorna`s contact details
***********@emulatebio.com
Colleagues
Vice President of People
Vice President, Platform Development
Co-Founder, Chief Technology Officer and Board Member
Chief Executive Officer